Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder
Open Access
- 11 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Psychiatry
- Vol. 11 (1), 1-13
- https://doi.org/10.1038/s41398-020-01148-y
Abstract
Predicting lithium response (LiR) in bipolar disorder (BD) may inform treatment planning, but phenotypic heterogeneity complicates discovery of genomic markers. We hypothesized that patients with “exemplary phenotypes”—those whose clinical features are reliably associated with LiR and non-response (LiNR)—are more genetically separable than those with less exemplary phenotypes. Using clinical data collected from people with BD (n = 1266 across 7 centers; 34.7% responders), we computed a “clinical exemplar score,” which measures the degree to which a subject’s clinical phenotype is reliably predictive of LiR/LiNR. For patients whose genotypes were available (n = 321), we evaluated whether a subgroup of responders/non-responders with the top 25% of clinical exemplar scores (the “best clinical exemplars”) were more accurately classified based on genetic data, compared to a subgroup with the lowest 25% of clinical exemplar scores (the “poor clinical exemplars”). On average, the best clinical exemplars of LiR had a later illness onset, completely episodic clinical course, absence of rapid cycling and psychosis, and few psychiatric comorbidities. The best clinical exemplars of LiR and LiNR were genetically separable with an area under the receiver operating characteristic curve of 0.88 (IQR [0.83, 0.98]), compared to 0.66 [0.61, 0.80] (p = 0.0032) among poor clinical exemplars. Variants in the Alzheimer’s amyloid–secretase pathway, along with G-protein-coupled receptor, muscarinic acetylcholine, and histamine H1R signaling pathways were informative predictors. This study must be replicated on larger samples and extended to predict response to other mood stabilizers.This publication has 36 references indexed in Scilit:
- Risks of all-cause and suicide mortality in mental disorders: a meta-reviewWorld Psychiatry, 2014
- Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) ReportPLOS ONE, 2013
- Genetic risk of suicidal behavior in bipolar spectrum disorder: analysis of 737 pedigreesBipolar Disorders, 2013
- Duration of untreated bipolar disorder: missed opportunities on the long road to optimal treatmentActa Psychiatrica Scandinavica, 2012
- The International Consortium on Lithium Genetics (ConLiGen): An Initiative by the NIMH and IGSLI to Study the Genetic Basis of Response to Lithium TreatmentNeuropsychobiology, 2010
- Lithium specificity in bipolar illness: a classic agent for the classic disorderBipolar Disorders, 2009
- Identifying predictors for good lithium response – A retrospective analysis of 100 patients with bipolar disorder using a life-charting methodEuropean Psychiatry, 2009
- Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disordersBipolar Disorders, 2005
- The phenotypic spectra of bipolar disorderEuropean Neuropsychopharmacology, 2004
- Is Response to Prophylactic Lithium a Familial Trait?British Journal of Psychology, 2002